KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Estee Lauder Companies (EL) Common Equity (2016 - 2025)

Estee Lauder Companies has reported Common Equity over the past 17 years, most recently at $4.0 billion for Q4 2025.

  • Quarterly results put Common Equity at $4.0 billion for Q4 2025, down 3.31% from a year ago — trailing twelve months through Dec 2025 was $4.0 billion (down 3.31% YoY), and the annual figure for FY2025 was $3.9 billion, down 71.21%.
  • Common Equity for Q4 2025 was $4.0 billion at Estee Lauder Companies, up from $8.0 million in the prior quarter.
  • Over the last five years, Common Equity for EL hit a ceiling of $13.8 billion in Q3 2023 and a floor of -$13.7 billion in Q1 2024.
  • Median Common Equity over the past 5 years was $4.3 billion (2024), compared with a mean of $2.8 billion.
  • Biggest five-year swings in Common Equity: soared 38007.14% in 2021 and later plummeted 332.48% in 2024.
  • Estee Lauder Companies' Common Equity stood at $5.3 billion in 2021, then plummeted by 355.24% to -$13.6 billion in 2022, then surged by 146.76% to $6.4 billion in 2023, then tumbled by 34.52% to $4.2 billion in 2024, then dropped by 3.31% to $4.0 billion in 2025.
  • The last three reported values for Common Equity were $4.0 billion (Q4 2025), $8.0 million (Q3 2025), and $3.9 billion (Q2 2025) per Business Quant data.